Topic Overview

Atrial
fibrillation is the most common type of supraventricular tachycardia. For
information on this condition, see the topic
Atrial Fibrillation. If you have ventricular
tachycardia, see the topic
Ventricular Tachycardia.
What is supraventricular tachycardia?
Supraventricular tachycardia (SVT) is an abnormal fast heart rhythm that
starts in the upper chambers, or the atria, of the heart. ("Supraventricular"
means above the ventricles, "tachy" means fast, and "cardia" means
heart.)
Normally, the heart's electrical system precisely controls
the rhythm and rate at which the heart beats. In supraventricular tachycardia,
abnormal electrical connections (or abnormal firing of the connections) cause
the heart to beat too fast. Typically, during supraventricular tachycardia
episodes, the heart beats faster than 100 beats per minute. Sometimes the heart
beats as fast as 300 beats per minute. Usually, the heart returns to a normal
rate (60 to 100 beats per minute) on its own or after treatment.
Supraventricular tachycardia (SVT) is also called paroxysmal
supraventricular tachycardia (PSVT) or paroxysmal atrial tachycardia
(PAT).
What are the different types of supraventricular tachycardia?
Sometimes it is normal to have an increased heart
rate—for example, during exercise, with a high fever, or when under stress.
This fast heart rate, called sinus tachycardia, is a normal response to these
stressors and is not considered a medical problem. This topic addresses the
types of supraventricular tachycardias that are considered abnormal. These
include:
What causes supraventricular tachycardia?
Most
supraventricular tachycardia results from abnormal
electrical connections in the heart
that short-circuit
the normal electrical system. What causes these abnormal pathways is not clear.
In the case of Wolff-Parkinson-White syndrome, the condition may be
inherited.
Some medicines can cause
supraventricular tachycardia. Overly high levels of the heart medicine digoxin
(such as Lanoxicaps or Lanoxin) can cause some types of supraventricular
tachycardia (such as Wolff-Parkinson-White syndrome) to get worse. But digoxin
may be used to treat some other types of SVT (such as atrial fibrillation). The
bronchodilator theophylline may also cause
tachycardia.
In rare cases, conditions that affect the lungs—such
as
chronic obstructive pulmonary disease (COPD) or
pneumonia—can also cause a type of SVT called
multifocal atrial tachycardia (MAT).
What are the symptoms?
With supraventricular
tachycardia, you may have
palpitations, an uncomfortable feeling that your heart
is racing or pounding. You may also notice that your pulse is rapid or see or
feel your pulse pounding, especially at your neck, where large arteries are
close to the skin. Other symptoms include feeling dizzy or lightheaded,
near-fainting or fainting (syncope), shortness of breath, chest
pain, throat tightness, and sweating.
How is supraventricular tachycardia diagnosed?
A
description of your symptoms is one of the most important clues in diagnosing
supraventricular tachycardia. Your doctor will ask what, if anything, triggers
the episodes, how long they last, if they start and stop suddenly, whether
anything stops them, and whether the beats are regular or irregular.
Because supraventricular tachycardia is a problem with your heart's
electrical system, the most important test is an
electrocardiogram (EKG, ECG). An EKG measures the
heart's electrical activity and can record supraventricular tachycardia
episodes. An EKG is usually done along with a medical history and physical
examination, lab tests, and a chest
X-ray.
If you do not have an episode of
supraventricular tachycardia while at the doctor's office, your doctor will
probably ask you to wear a portable EKG to record your heart rhythm on a
continuous basis. This is referred to by several names, including ambulatory
electrocardiogram, ambulatory ECG, Holter monitoring, 24-hour EKG, or cardiac
event monitoring. This will allow your heart rhythm to be recorded while you
are having supraventricular tachycardia.
Your doctor may also
recommend an electrophysiology (EP) study. In this test, flexible wires are
inserted into a vein, usually in the groin, and threaded into the heart.
Electrodes at the end of the wires send information about the heart's
electrical activity. In this way, the EP study can map any abnormal electrical
activity, identify the type of supraventricular tachycardia you have, and guide
treatment.
How is it treated?
Some supraventricular
tachycardias do not cause symptoms and may not need treatment. But when
symptoms occur, treatment is usually recommended.
Your doctor may
teach you how to perform vagal maneuvers, such as the
Valsalva maneuver or coughing, to slow your heart
rate. If vagal maneuvers do not work, a fast-acting
intravenous (IV) medicine such as adenosine or
verapamil can be given. If the arrhythmia does not stop and symptoms are
severe,
electrical cardioversion, in which a brief electric
shock is given to the heart to reset the heart rhythm, may be needed.
If supraventricular tachycardia recurs, you may need long-term treatment,
including:
- Beta-blockers or other
antiarrhythmic medicines to prevent an episode or to
slow the heart rate.
- Catheter ablation, which is usually done
during an electrophysiology (EP) study. The most common type of catheter
ablation uses radio waves (radiofrequency energy). These waves are directed
through the catheter to the specific heart tissue that is generating abnormal
electrical impulses. The radio waves cause the area of the heart muscle to be
heated and selectively destroyed, eliminating the SVT.
What precautions should I take?
Avoid consuming
large amounts of alcohol or caffeine, either of which may provoke episodes of
supraventricular tachycardia. Also, nonprescription decongestants, herbal
remedies, diet pills, and "pep" pills often contain stimulants and should be
avoided. Illegal drugs, such as stimulants like cocaine, ecstasy, or
methamphetamine, also can trigger episodes. It is important to be aware of
which substances have an effect on you and to avoid them.